The historic decision to reclassify marijuana from a Schedule I drug to Schedule III came April 30. The Drug Enforcement Agency’s ruling was driven by guidance published by the Department of Health ...
DEA Reschedules FDA-Approved Marijuana Products and State-Licensed Medical Marijuana to Schedule III
On April 22, 2026, Acting Attorney General Todd Blanche signed a final order transferring U.S. Food and Drug Administration (FDA)-approved marijuana products and marijuana subject to state-licensed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results